Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids

ClinicalTrials.gov ID: NCT06224348

Public ClinicalTrials.gov record NCT06224348. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 3:44 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel Group, 3-arm, Multinational, Multicenter Study to Evaluate the Efficacy and Safety of Amlitelimab by Subcutaneous Injection in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids

Study identification

NCT ID
NCT06224348
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sanofi
Industry
Enrollment
643 participants

Conditions and interventions

Interventions

  • Amlitelimab Drug
  • Placebo Drug
  • Topical calcineurin inhibitors Drug
  • Topical corticosteroids Drug

Drug

Eligibility (public fields only)

Age range
12 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 17, 2024
Primary completion
Aug 20, 2025
Completion
Oct 31, 2025
Last update posted
Dec 1, 2025

2024 – 2025

United States locations

U.S. sites
40
U.S. states
20
U.S. cities
35
Facility City State ZIP Site status
Cahaba Dermatology & Skin Health Center- Site Number : 8401066 Birmingham Alabama 35244
Johnson Dermatology- Site Number : 8401076 Fort Smith Arkansas 72916
Encino Research Center- Site Number : 8401042 Encino California 91436
Marvel Clinical Research- Site Number : 8401102 Huntington Beach California 92647
LA Universal Research Center- Site Number : 8401064 Los Angeles California 90057
Cura Clinical Research- Site Number : 8401141 Palmdale California 93551
Integrative Skin Science and Research- Site Number : 8401275 Sacramento California 95815
Southern California Dermatology- Site Number : 8401043 Santa Ana California 92701
Skin Care Research - Hollywood- Site Number : 8401071 Hollywood Florida 33021
Clever Medical Research- Site Number : 8401160 Miami Florida 33126
Acevedo Clinical Research Associates- Site Number : 8401088 Miami Florida 33142
Palm Springs Community Health Center- Site Number : 8401264 Miami Lakes Florida 33016
Global Clinical Professionals (GCP)- Site Number : 8401045 St. Petersburg Florida 33705
University of South Florida- Site Number : 8401070 Tampa Florida 33612
Avita Clinical Research- Site Number : 8401073 Tampa Florida 33613
Cleaver Medical Group- Site Number : 8401138 Dawsonville Georgia 30534
NorthShore University HealthSystem - Skokie Hospital- Site Number : 8401038 Skokie Illinois 60076
Dawes Fretzin Clinical Research- Site Number : 8401015 Indianapolis Indiana 46256
BRCR Global Gretna- Site Number : 8401243 Gretna Louisiana 70053
Velocity Clinical Research - New Orleans- Site Number : 8401155 New Orleans Louisiana 70119
Oakland Medical Center- Site Number : 8401116 Troy Michigan 48085
Allergy & Immunology Associates of Ann Arbor- Site Number : 8401078 Ypsilanti Michigan 48197
Dermatology and Skin Cancer Lee's Summit- Site Number : 8401157 Lee's Summit Missouri 64064
Skin Specialists- Site Number : 8401068 Omaha Nebraska 68144
Jubilee Clinical Research- Site Number : 8401054 Las Vegas Nevada 89106
Allcutis Research - Portsmouth- Site Number : 8401082 Portsmouth New Hampshire 03801
Equity Medical- Site Number : 8401239 New York New York 10023
Icahn School of Medicine at Mount Sinai- Site Number : 8401129 New York New York 10029
OptiSkin- Site Number : 8401163 New York New York 10128
Apex Clinical Research Center- Site Number : 8401237 Mayfield Heights Ohio 44124
Essential Medical Research- Site Number : 8401183 Tulsa Oklahoma 74137
Vial Health - DermDox Dermatology- Site Number : 8401031 Camp Hill Pennsylvania 17011
Clinical Research Center of the Carolinas- Site Number : 8401067 Charleston South Carolina 29407
SMS Clinical Research- Site Number : 8401182 Mesquite Texas 75149
Sienna Dermatology- Site Number : 8401148 Missouri City Texas 77459
Texas Dermatology and Laser Specialists- Site Number : 8401131 San Antonio Texas 78218
Discovery Clinical Trials - San Antonio - Stone Oak Parkway- Site Number : 8401026 San Antonio Texas 78258
Complete Dermatology - Sugar Land- Site Number : 8401061 Sugar Land Texas 77479
Cope Family Medicine - Ogden Clinic- Site Number : 8401114 Bountiful Utah 84010
Tanner Clinic - Layton Antelope A- Site Number : 8401151 Layton Utah 84041

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 127 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06224348, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 1, 2025 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06224348 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →